Sepsis and Septic Shock: Current Treatment Strategies and New Approaches
- PMID: 28416934
- PMCID: PMC5389495
- DOI: 10.5152/eurasianjmed.2017.17062
Sepsis and Septic Shock: Current Treatment Strategies and New Approaches
Abstract
Sepsis is a complex condition characterized by the simultaneous activation of inflammation and coagulation in response to microbial insult. These events manifest as systemic inflammatory response syndrome or sepsis symptoms through the release of proinflammatory cytokines, procoagulants, and adhesion molecules from immune cells and/or damaged endothelium. Today, sepsis is a severe multisystem disease with difficult treatments for its manifestations and high mortality rates. In the last two decades in particular, many studies have been conducted on sepsis that cause shock, multiorgan dysfunction, and organ failure by especially leading to hemodynamic changes. In sepsis, increasing antibiotic resistance and medicine-resistant hemodynamic changes have resulted in further research on new treatment modalities in addition to classical treatments. In the last decade, the sepsis physiopathology has been elucidated. Various therapeutic agents have been used in addition to antibiotherapy, but no satisfactory results have been obtained. This review summarizes the sepsis pathophysiology, current treatment protocols, and new approaches.
Sepsis, mikrobiyal maruziyet sonrasında enflamasyon ve koagülasyonun birlikte aktive olmasıyla karakterize komleks bir sendromdur. Bu olaylar, immün hücreler veya hasar görmüş endotel hücrelerinden salınan proinflamatuvar sitokinler, prokoagülanlar ve adezyon molekülleri yoluyla sistemik enflamatuvar yanıt sendromu veya sepsis bulguları ile ortaya çıkar. Sepsis, günümüzde halen yüksek mortalite ile seyreden tedavisi güç bir klinik tablodur. Birçok sistemi tutan, özellikle hemodinamik değişikliklere yol açarak şok, organ fonksiyon bozukluğu ve organ yetmezliğine giden sepsis hakkında özellikle son yirmi yılda pek çok çalışma yapılmıştır. Sepsiste özellikle artan antibiyotik direnci ve septik şok fazındaki tedaviye dirençli hemodinamik değişiklikler, klasik tedavilere ek olarak yeni tedavi teknikleri geliştirme çabalarına neden olmuştur. Fizyopatolojisi daha iyi anlaşıldıkça, antibiyotik tedavisine ilave olarak birçok ajan denenmiş ama hala yeterli sonuçlar elde edilememiştir. Bu derlemede sepsis patofizyolojisi, mevcut tedavileri ve yeni yaklaşımları özetlenmiştir.
Keywords: Critical care; sepsis; septic shock.
Conflict of interest statement
Conflict of Interest: No conflict of interest was declared by the authors.
Similar articles
-
The puzzle of sepsis: fitting the pieces of the inflammatory response with treatment.AACN Clin Issues. 2004 Jan-Mar;15(1):18-44. doi: 10.1097/00044067-200401000-00003. AACN Clin Issues. 2004. PMID: 14767363 Review.
-
Sepsis Care Pathway 2019.Qatar Med J. 2019 Nov 7;2019(2):4. doi: 10.5339/qmj.2019.qccc.4. eCollection 2019. Qatar Med J. 2019. PMID: 31763206 Free PMC article.
-
[[Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] ].Minerva Anestesiol. 2000 Nov;66(11 Suppl 1):3-23. Minerva Anestesiol. 2000. PMID: 11213542 Review. Italian.
-
[Physiopathology of severe sepsis].Presse Med. 2004 Feb 28;33(4):256-61; discussion 269. doi: 10.1016/s0755-4982(04)98551-x. Presse Med. 2004. PMID: 15029017 Review. French.
-
Septic shock, multiple organ failure, and acute respiratory distress syndrome.Curr Opin Pulm Med. 2003 May;9(3):199-209. doi: 10.1097/00063198-200305000-00008. Curr Opin Pulm Med. 2003. PMID: 12682565 Review.
Cited by
-
Sepsis: Inflammation Is a Necessary Evil.Front Cell Dev Biol. 2019 Jun 20;7:108. doi: 10.3389/fcell.2019.00108. eCollection 2019. Front Cell Dev Biol. 2019. PMID: 31281814 Free PMC article. Review.
-
Therapeutic Potential of Rhododendron arboreum Polysaccharides in an Animal Model of Lipopolysaccharide-Inflicted Oxidative Stress and Systemic Inflammation.Molecules. 2020 Dec 21;25(24):6045. doi: 10.3390/molecules25246045. Molecules. 2020. PMID: 33371296 Free PMC article.
-
Bacteriological profile and antibiogram of blood culture isolates from bloodstream infections in a rural tertiary hospital in Nigeria.Afr J Lab Med. 2022 Aug 24;11(1):1807. doi: 10.4102/ajlm.v11i1.1807. eCollection 2022. Afr J Lab Med. 2022. PMID: 36091350 Free PMC article.
-
Unveiling signaling pathways inducing MHC class II expression in neutrophils.Front Immunol. 2024 Sep 30;15:1444558. doi: 10.3389/fimmu.2024.1444558. eCollection 2024. Front Immunol. 2024. PMID: 39403371 Free PMC article.
-
Anti-Endotoxin 9-Meric Peptide with Therapeutic Potential for the Treatment of Endotoxemia.J Microbiol Biotechnol. 2021 Jan 28;31(1):25-32. doi: 10.4014/jmb.2011.11011. J Microbiol Biotechnol. 2021. PMID: 33263333 Free PMC article.
References
-
- Bone RC, Grodzin CJ, Balk RA. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest. 1997;112:235–43. https://doi.org/10.1378/chest.112.1.235. - DOI - PubMed
-
- Cohen J. The immunopathogenesis of sepsis. Nature. 2002;420:885–91. https://doi.org/10.1038/nature01326. - DOI - PubMed
-
- Marx G, Schuerholz T, Reinhart K. New approaches to intensive care for sepsis. Chirurg. 2005;76:845–55. https://doi.org/10.1007/s00104-005-1076-0. - DOI - PubMed
-
- Pittet D, Li N, Woolson RF, Wenzel RP. Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. Clin Infect Dis. 1997;24:1068–78. https://doi.org/10.1086/513640. - DOI - PubMed
-
- Uzun O, Akalin HE, Hayran M, Unal S. Factors influencing prognosis in bacteremia due to gram-negative organisms: evaluation of 448 episodes in a Turkish university hospital. Clin Infect Dis. 1992;15:866–73. https://doi.org/10.1093/clind/15.5.866. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources